By Business/Source
Currency:USD
2025/FY
Stock NameRevenueRatio
Development of differentiated therapies to treat inflammatory and immune-mediated conditions of high570K100.00%
By Country/Region
Currency:USD
2025/FY
Stock NameRevenueRatio
United States570K100.00%